BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17674242)

  • 1. A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.
    Geier DA; Geier MR
    J Matern Fetal Neonatal Med; 2007 May; 20(5):385-90. PubMed ID: 17674242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.
    Geier DA; Mumper E; Gladfelter B; Coleman L; Geier MR
    Neuro Endocrinol Lett; 2008 Apr; 29(2):272-80. PubMed ID: 18404135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.
    Geier DA; Geier MR
    J Toxicol Environ Health A; 2007 May; 70(10):837-51. PubMed ID: 17454560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
    Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
    Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to anti-D immune globulin and autism risk: Croen et al.
    DeFranco E; Gross G; Shanks A; Johnson T; Shen T
    Am J Obstet Gynecol; 2008 Sep; 199(3):322-3. PubMed ID: 18772000
    [No Abstract]   [Full Text] [Related]  

  • 7. Discussion: Prenatal exposure to anti-D immune globulin and autism risk by Croen et al.
    DeFranco E; Gross G; Shanks A; Johnson T; Shen T
    Am J Obstet Gynecol; 2008 Sep; 199(3):e1-4. PubMed ID: 18771966
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of association between Rh status, Rh immune globulin in pregnancy and autism.
    Miles JH; Takahashi TN
    Am J Med Genet A; 2007 Jul; 143A(13):1397-407. PubMed ID: 17508426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders.
    Croen LA; Matevia M; Yoshida CK; Grether JK
    Am J Obstet Gynecol; 2008 Sep; 199(3):234.e1-6. PubMed ID: 18554566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA; Geier MR
    Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D; Geier MR
    Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK; Schwartz B; Todd J; Pickering LK
    Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
    Geier DA; Geier MR
    Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure.
    Geier DA; Geier MR
    Neurotox Res; 2006 Aug; 10(1):57-64. PubMed ID: 17000470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies.
    Geier DA; Geier MR
    Neuro Endocrinol Lett; 2007 Oct; 28(5):565-73. PubMed ID: 17984958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit/hyperactivity disorder in the childhood.
    Yoshimasu K; Kiyohara C; Takemura S; Nakai K
    Neurotoxicology; 2014 Sep; 44():121-31. PubMed ID: 24952233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
    Schechter R; Grether JK
    Arch Gen Psychiatry; 2008 Jan; 65(1):19-24. PubMed ID: 18180424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mercury and autism: accelerating evidence?
    Mutter J; Naumann J; Schneider R; Walach H; Haley B
    Neuro Endocrinol Lett; 2005 Oct; 26(5):439-46. PubMed ID: 16264412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal.
    Singh VK; Hanson J
    Pediatr Allergy Immunol; 2006 Jun; 17(4):291-6. PubMed ID: 16771783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy.
    Johnson WG; Buyske S; Mars AE; Sreenath M; Stenroos ES; Williams TA; Stein R; Lambert GH
    Arch Pediatr Adolesc Med; 2009 Jun; 163(6):542-6. PubMed ID: 19487610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.